-
Dr Caroline Copeland
Lecturer in Pharmaceutical Medicine
Profile
Dr Caroline Copeland is a Lecturer in Pharmaceutical Medicine at King’s College London. Following her undergraduate and postgraduate studies at University College London and Imperial College, respectively, she completed a PhD with Prof Tom Salt and Prof Adam Sillito in the neuropharmacology and neurophysiology of thalamocortical circuits. Following her PhD she completed post-doctoral work with Prof Simon Schultz at Imperial College, before moving to St George’s, University of London, where she applied her neuropharmacology and mathematical modelling skills to the pharmacoepidemiology of drug-related deaths, later becoming the Director of the National Programme on Substance Abuse Deaths. She joined King’s in September 2019, and heads a research group whose projects have the broad collective aim of improving healthcare strategies for people who use drugs. Current projects range from the development of a wearable skin sensor to protect against opioid overdose, to the identification of drug-drug interactions between licensed medicines and illicit substances to prevent adverse effects. Dr Copeland also sits on the Home Office’s Advisory Council for the Misuse of Drugs Novel Psychoactive Substances (ACMD NPS) Sub-Committee, and the Welsh National Implementation Board for Drug Poisoning Prevention (NIBDPP). In these roles she examines how national and international drug policy influences drug-related death trends.